BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Gene expression differences between highly enriched normal and chronic myelogenous leukemia quiescent stem/progenitor cells and...

Dataset: Gene expression differences between highly enriched normal and chronic myelogenous leukemia quiescent stem/progenitor cells and correlations with biological abnormalities

In comparing gene expression of normal and CML CD34+ quiescent (G0) and proliferating (G1/S/G2/M) cells, 292 genes were down-regulated...

Registered by ArrayExpress Uploader
View Dataset

In comparing gene expression of normal and CML CD34+ quiescent (G0) and proliferating (G1/S/G2/M) cells, 292 genes were down-regulated and 192 genes were up-regulated in the CML G0 cells. The differentially expressed genes were grouped according to their reported functions and correlations were sought with biological differences previously observed between the same groups. The most apparent correlations include: i) Normal and CML G0 cells are more primitive than G1/S/G2/M cells; ii) CML G0 cells are in a more advanced stage of development and more poised to begin proliferating than normal G0 cells; iii) When CML G0 cells are stimulated to proliferate, they undergo further differentiation and maturation more rapidly than normal G0 cells, but both granulopoiesis and erythropoiesis are less efficient than normal; iv) Whereas normal G0 cells form only granulocyte/monocyte (GM) colonies when stimulated by cytokines, CML G0 cells consistently form a combination of GM and erythroid clusters and colonies; and v) Prominin-1 (CD133) is the gene most down-regulated in CML G0 cells and its down-regulation appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. The gene most over-expressed in CML G0 cells is LepR, but its role in contributing to the myeloid expansion and other abnormalities is unknown. It was hoped that LepR might serve as a therapeutic target, but leptin had no stimulatory or inhibitory effect on either normal or CML G0 cells, our attempts to make a specific LepR antibody were unsuccessful, and no other potentially targetable over-expressed surface antigens were identified. A total of eight patients diagnosed with Ph+ CML (three in accelerated phase and five in chronic phase) were used in this study. The CML samples were all obtained from patients hospitalized at the Memorial Sloan Kettering during the period 1990-2006. The four normal bone marrow samples were purchased from Cambrex (Cambrex Bio Science Rockland,Inc., Rockland, Maine 04841, USA).

Species:
human

Samples:
24

Source:
E-GEOD-24739

Updated:
Dec.12, 2014

Registered:
Sep.15, 2014


Factors: (via ArrayExpress)
Sample DISEASE STATE TISSUE CML PHASE CELL CYCLE PHASE
GSM609346 chronic myelogenous leukemia (CML) peripheral blood chronic G0
GSM609346 chronic myelogenous leukemia (CML) peripheral blood chronic G0
GSM609348 chronic myelogenous leukemia (CML) peripheral blood accelerated G0
GSM609346 chronic myelogenous leukemia (CML) peripheral blood chronic G0
GSM609348 chronic myelogenous leukemia (CML) peripheral blood accelerated G0
GSM609348 chronic myelogenous leukemia (CML) peripheral blood accelerated G0
GSM609346 chronic myelogenous leukemia (CML) peripheral blood chronic G0
GSM609346 chronic myelogenous leukemia (CML) peripheral blood chronic G0
GSM609354 normal bone marrow not specified G0
GSM609354 normal bone marrow not specified G0
GSM609354 normal bone marrow not specified G0
GSM609354 normal bone marrow not specified G0
GSM609358 chronic myelogenous leukemia (CML) peripheral blood chronic G1/S/G2/M
GSM609358 chronic myelogenous leukemia (CML) peripheral blood chronic G1/S/G2/M
GSM609360 chronic myelogenous leukemia (CML) peripheral blood accelerated G1/S/G2/M
GSM609358 chronic myelogenous leukemia (CML) peripheral blood chronic G1/S/G2/M
GSM609360 chronic myelogenous leukemia (CML) peripheral blood accelerated G1/S/G2/M
GSM609360 chronic myelogenous leukemia (CML) peripheral blood accelerated G1/S/G2/M
GSM609358 chronic myelogenous leukemia (CML) peripheral blood chronic G1/S/G2/M
GSM609358 chronic myelogenous leukemia (CML) peripheral blood chronic G1/S/G2/M
GSM609366 normal bone marrow not specified G1/S/G2/M
GSM609366 normal bone marrow not specified G1/S/G2/M
GSM609366 normal bone marrow not specified G1/S/G2/M
GSM609366 normal bone marrow not specified G1/S/G2/M

Tags

  • bone
  • bone marrow
  • cml
  • monocyte
  • surface

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use